Tuesday, 14 February 2017

Company Delays Launch of Muscular Dystrophy Drug

The U.S. launch of a drug for a rare disorder called Duchenne muscular dystrophy will be paused due to concerns about its price



from WebMD Health http://ift.tt/2l5puwg

No comments:

Post a Comment